Identification and validation of stromal-tumor microenvironment-based subtypes tightly associated with PD-1/PD-L1 immunotherapy and outcomes in patients with gastric cancer

BACKGROUND: Immunotherapies targeting programmed cell death 1 (PD-1) and programmed death-ligand 1 (PD-L1) have been approved for gastric cancer (GC) patients. However, a large proportion of patients with T-cell-inflamed tumor microenvironment do not respond to the PD-1/PD-L1 blockade. The stromal c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Qianqian, Zhu, Peng, Zhang, Hui, Ye, Tianhe, Liu, Dehan, Gong, Zhao, Xia, Xiangwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092673/
https://www.ncbi.nlm.nih.gov/pubmed/32226313
http://dx.doi.org/10.1186/s12935-020-01173-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092673/
https://www.ncbi.nlm.nih.gov/pubmed/32226313
http://dx.doi.org/10.1186/s12935-020-01173-3

Ejemplares similares